All Relations between Schizophrenia and Clozapine

Publication Sentence Publish Date Extraction Date Species
Jari-Pekka Klemettilä, Olli Kampman, Niko Seppälä, Merja Viikki, Mari Hämäläinen, Eeva Moilanen, Esa Leinone. Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine. Psychiatry research. vol 218. issue 3. 2014-12-10. PMID:24837425. metabolic syndrome is associated with both schizophrenia and antipsychotic medication, especially clozapine, with alterations in inflammatory cytokines and adipokines. 2014-12-10 2023-08-13 Not clear
Jari-Pekka Klemettilä, Olli Kampman, Niko Seppälä, Merja Viikki, Mari Hämäläinen, Eeva Moilanen, Esa Leinone. Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine. Psychiatry research. vol 218. issue 3. 2014-12-10. PMID:24837425. in this study we assessed the serum levels of cytokines/adipokines il-6, il-1ra, hs-crp and adiponectin, and components of metabolic syndrome in 190 patients with treatment resistant schizophrenia treated with clozapine. 2014-12-10 2023-08-13 Not clear
Jari-Pekka Klemettilä, Olli Kampman, Niko Seppälä, Merja Viikki, Mari Hämäläinen, Eeva Moilanen, Esa Leinone. Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine. Psychiatry research. vol 218. issue 3. 2014-12-10. PMID:24837425. we conclude that there are partly gender dependent cytokine and adipokine alterations in patients with schizophrenia on clozapine treatment associated with metabolic comorbidity. 2014-12-10 2023-08-13 Not clear
Nazife Gamze Usta, Cana Aksoy Poyraz, Melih Aktan, Alaattin Dura. Clozapine treatment of refractory schizophrenia during essential chemotherapy: a case study and mini review of a clinical dilemma. Therapeutic advances in psychopharmacology. vol 4. issue 6. 2014-12-09. PMID:25489479. clozapine treatment of refractory schizophrenia during essential chemotherapy: a case study and mini review of a clinical dilemma. 2014-12-09 2023-08-13 Not clear
Nazife Gamze Usta, Cana Aksoy Poyraz, Melih Aktan, Alaattin Dura. Clozapine treatment of refractory schizophrenia during essential chemotherapy: a case study and mini review of a clinical dilemma. Therapeutic advances in psychopharmacology. vol 4. issue 6. 2014-12-09. PMID:25489479. clozapine remains the antipsychotic of choice for refractory schizophrenia. 2014-12-09 2023-08-13 Not clear
Johann Steiner, Daniel Martins-de-Souza, Kolja Schiltz, Zoltan Sarnyai, Sabine Westphal, Berend Isermann, Henrik Dobrowolny, Christoph W Turck, Bernhard Bogerts, Hans-Gert Bernstein, Tamas L Horvath, Lorenz Schild, Gerburg Keilhof. Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes. Frontiers in cellular neuroscience. vol 8. 2014-12-05. PMID:25477781. our findings support the superior impact of clozapine on white matter integrity in schizophrenia as previously observed, suggesting that this drug improves the energy supply and myelin lipid synthesis in oligodendrocytes. 2014-12-05 2023-08-13 Not clear
Cicek Hocaogl. Clozapine-induced rabbit syndrome: a case report. Mental illness. vol 1. issue 1. 2014-12-05. PMID:25478081. we present the case history of a 44-year old female patient treated for paranoid schizophrenia for 22 years and rs during her last 10-month clozapine treatment. 2014-12-05 2023-08-13 rabbit
Eila Repo-Tiihonen, Tero Hallikainen, Päivi Kivistö, Jari Tiihone. Antipsychotic Polypharmacy in Clozapine Resistant Schizophrenia: A Randomized Controlled Trial of Tapering Antipsychotic Co-treatment. Mental illness. vol 4. issue 1. 2014-12-05. PMID:25478102. antipsychotic polypharmacy in clozapine resistant schizophrenia: a randomized controlled trial of tapering antipsychotic co-treatment. 2014-12-05 2023-08-13 human
Eila Repo-Tiihonen, Tero Hallikainen, Päivi Kivistö, Jari Tiihone. Antipsychotic Polypharmacy in Clozapine Resistant Schizophrenia: A Randomized Controlled Trial of Tapering Antipsychotic Co-treatment. Mental illness. vol 4. issue 1. 2014-12-05. PMID:25478102. there is a considerable disparity between clinical practice and recommendations based on meta-analyses of antipsychotic polypharmacy in clozapine resistant schizophrenia. 2014-12-05 2023-08-13 human
H Y Meltzer, J-P Lindenmayer, J Kwentus, D B Share, R Johnson, K Jayathilak. A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia. Schizophrenia research. vol 154. issue 1-3. 2014-11-26. PMID:24630262. it has been suggested that atypical antipsychotic drugs (a-apds) other than clozapine may be effective to improve positive symptoms in some patients with treatment resistant schizophrenia (trs), if both the dose is higher, and the duration of the trial longer, than those which have been ineffective in non-trs (ntrs) patients. 2014-11-26 2023-08-12 Not clear
Marta Bosia, Andrea Zanoletti, Marco Spangaro, Mariachiara Buonocore, Margherita Bechi, Federica Cocchi, Adele Pirovano, Cristina Lorenzi, Placido Bramanti, Enrico Smeraldi, Roberto Cavallar. Factors affecting cognitive remediation response in schizophrenia: the role of COMT gene and antipsychotic treatment. Psychiatry research. vol 217. issue 1-2. 2014-11-26. PMID:24656901. in the present study, we analyzed the interaction between pharmacological treatment (clozapine vs typical/atypical d2 blockers) and comt rs4680 polymorphism on cognitive changes after cognitive remediation therapy, in a sample of 98 clinically stabilized patients with schizophrenia. 2014-11-26 2023-08-12 Not clear
Jong-Hoon Kim, Jinyoung Lee, Young-Bo Kim, Ah-young Ha. Association between subjective well-being and depressive symptoms in treatment-resistant schizophrenia before and after treatment with clozapine. Comprehensive psychiatry. vol 55. issue 3. 2014-11-18. PMID:24332387. association between subjective well-being and depressive symptoms in treatment-resistant schizophrenia before and after treatment with clozapine. 2014-11-18 2023-08-12 Not clear
Jong-Hoon Kim, Jinyoung Lee, Young-Bo Kim, Ah-young Ha. Association between subjective well-being and depressive symptoms in treatment-resistant schizophrenia before and after treatment with clozapine. Comprehensive psychiatry. vol 55. issue 3. 2014-11-18. PMID:24332387. we examined the relationship between subjective well-being and depressive symptoms in patients with treatment-resistant schizophrenia before and after treatment with clozapine to contribute to the growing body of research regarding the determinants of patients' perspective of their own well-being in schizophrenia. 2014-11-18 2023-08-12 Not clear
Eesha Sharma, Naren P Rao, Ganesan Venkatasubramania. Association between antipsychotic-induced metabolic side-effects and clinical improvement: a review on the Evidence for "metabolic threshold". Asian journal of psychiatry. vol 8. 2014-11-18. PMID:24655620. findings from these studies depict changes mainly in schizophrenia patients on treatment with clozapine or olanzapine. 2014-11-18 2023-08-12 Not clear
Nikolina Jovanović, Vanja Lovretić, Martina Rojnić Kuzma. The use of electroconvulsive therapy and general anaesthesia in catatonic schizophrenia complicated by clozapine - induced pancytopenia - case report. Psychiatria Danubina. vol 26. issue 3. 2014-11-18. PMID:25191778. the use of electroconvulsive therapy and general anaesthesia in catatonic schizophrenia complicated by clozapine - induced pancytopenia - case report. 2014-11-18 2023-08-13 Not clear
Elcin Ozcelik-Eroglu, Aygun Ertugrul, Kader Karli Oguz, Arzu Ceylan Has, Sevilay Karahan, Mumin Kazim Yazic. Effect of clozapine on white matter integrity in patients with schizophrenia: a diffusion tensor imaging study. Psychiatry research. vol 223. issue 3. 2014-11-17. PMID:25012780. effect of clozapine on white matter integrity in patients with schizophrenia: a diffusion tensor imaging study. 2014-11-17 2023-08-13 Not clear
Elcin Ozcelik-Eroglu, Aygun Ertugrul, Kader Karli Oguz, Arzu Ceylan Has, Sevilay Karahan, Mumin Kazim Yazic. Effect of clozapine on white matter integrity in patients with schizophrenia: a diffusion tensor imaging study. Psychiatry research. vol 223. issue 3. 2014-11-17. PMID:25012780. the study included 16 patients with schizophrenia who were assessed with the positive and negative syndrome scale, a neurocognitive test battery, and dti at baseline and 12 weeks after the initiation of clozapine treatment. 2014-11-17 2023-08-13 Not clear
Elcin Ozcelik-Eroglu, Aygun Ertugrul, Kader Karli Oguz, Arzu Ceylan Has, Sevilay Karahan, Mumin Kazim Yazic. Effect of clozapine on white matter integrity in patients with schizophrenia: a diffusion tensor imaging study. Psychiatry research. vol 223. issue 3. 2014-11-17. PMID:25012780. an increase in fa following 12 weeks of treatment with clozapine suggests that this treatment alters white matter microstructural integrity in patients with schizophrenia previously treated with typical and/or atypical antipsychotics and, in some locations, reverses a previous deficit. 2014-11-17 2023-08-13 Not clear
David T Chau, Jibran Y Khokhar, Ree Dawson, Jayme Ahmed, Haiyi Xie, Alan I Gree. The comparative effects of clozapine versus haloperidol on initiation and maintenance of alcohol drinking in male alcohol-preferring P rat. Alcohol (Fayetteville, N.Y.). vol 47. issue 8. 2014-11-12. PMID:24280363. recent data indicate that the atypical antipsychotic clozapine, but not the typical antipsychotic haloperidol, decreases alcohol drinking both in patients with schizophrenia and also in the syrian golden hamster, an animal model of moderate alcohol drinking. 2014-11-12 2023-08-12 rat
Stephanie Warnez, Silvia Alessi-Severin. Clozapine: a review of clinical practice guidelines and prescribing trends. BMC psychiatry. vol 14. 2014-11-06. PMID:24708834. clozapine effectiveness in the treatment of refractory schizophrenia has been sustained by published evidence in the last two decades, despite the introduction of safer options. 2014-11-06 2023-08-13 Not clear